These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 6368429)

  • 21. [Action of desoxyfructo-serotonin on Mycobacterium leprae. Results of inoculation of human biopsy specimens in the mouse after a year of treatment].
    Ferracci C; Baquillon G; Pattyn SR
    Acta Leprol; 1983; 1(4):233-5. PubMed ID: 6377799
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antibodies against Mycobacterium leprae antigen 7 from birth to 18 months of age: an indicator of intra-uterine infection in leprosy.
    Melsom R; Duncan ME; Harboe M; Bjune G
    Clin Exp Immunol; 1980 Oct; 42(1):107-13. PubMed ID: 7006873
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Failure of Mycobacterium leprae to incorporate tritiated thymidine administered in vivo.
    Evans MJ; Levy L
    Lepr Rev; 1977 Mar; 48(1):27-34. PubMed ID: 323610
    [No Abstract]   [Full Text] [Related]  

  • 24. The study of Mycobacterium leprae infection in interferon-gamma gene--disrupted mice as a model to explore the immunopathologic spectrum of leprosy.
    Adams LB; Scollard DM; Ray NA; Cooper AM; Frank AA; Orme IM; Krahenbuhl JL
    J Infect Dis; 2002 Feb; 185 Suppl 1():S1-8. PubMed ID: 11865434
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Trophic changes and extensive dissemination in normal mice infected with human Mycobacterium leprae.
    Vaishnavi C; Kaur S; Kumar B; Ganguly NK; Chakravarti RN
    Indian J Lepr; 1984; 56(4):742-7. PubMed ID: 6398338
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Therapeutic efficacy of some new quinolones and a combination of ofloxacin with rifampin against Mycobacterium leprae infection induced in athymic nude mice.
    Tomioka H; Saito H
    Int J Lepr Other Mycobact Dis; 1993 Jun; 61(2):250-4. PubMed ID: 8396614
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bacterial growth kinetics of "M. lufu" in the presence and absence of various drugs alone and in combination. A model for the development of combined chemotherapy against M. leprae?
    Seydel JK; Wempe EG
    Int J Lepr Other Mycobact Dis; 1982 Mar; 50(1):20-30. PubMed ID: 7042611
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vivo antileprosy activity of the newly synthesized benzoxazinorifamycin, KRM-1648.
    Tomioka H; Saito H
    Int J Lepr Other Mycobact Dis; 1993 Jun; 61(2):255-8. PubMed ID: 8371034
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synthesis and antileprosy activity of some dialkyldithiocarbamates.
    Makarov V; Riabova OB; Yuschenko A; Urlyapova N; Daudova A; Zipfel PF; Möllmann U
    J Antimicrob Chemother; 2006 Jun; 57(6):1134-8. PubMed ID: 16595643
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Therapeutic efficacy of benzoxazinorifamycin, KRM-1648, in combination with other antimicrobials against Mycobacterium leprae infection induced in nude mice.
    Saito H; Tomioka H; Sato K; Dekio S
    Int J Lepr Other Mycobact Dis; 1994 Mar; 62(1):43-7. PubMed ID: 8189088
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunoprophylaxis against Mycobacterium leprae infection with subunit vaccines.
    Britton WJ; Martin E; Kamath AT; Neupane KD; Roche PW
    Lepr Rev; 2000 Dec; 71 Suppl():S176-81. PubMed ID: 11201878
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Susceptibility to Mycobacterium leprae of ALY (alymphoplasia) mice and IFN-gamma induction in the culture supernatant of spleen cells.
    Yogi Y; Endoh M; Banba T; Okamura H; Nomaguchi H
    Int J Lepr Other Mycobact Dis; 1998 Dec; 66(4):464-74. PubMed ID: 10347567
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Resistance of Mycobacterium leprae to sulfones (DDS) and rifampicin in recurring lepromatous leprosy in Martinique and Guadeloupe since February 1980].
    Guelpa-Lauras CC; Constant-Desportes M; Millan J; Grosset J
    Acta Leprol; 1982; (86-87):77-80. PubMed ID: 6816000
    [No Abstract]   [Full Text] [Related]  

  • 34. Application of polymerase chain reaction for the detection of Mycobacterium leprae DNA in specimens from treated leprosy patients.
    Rafi A; Donoghue HD; Stanford JL
    Int J Lepr Other Mycobact Dis; 1995 Mar; 63(1):42-7. PubMed ID: 7730718
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Isolation and identification of mycolic acids in Mycobacterium leprae and Mycobacterium lepraemurium.
    Kusaka T; Kohsaka K; Fukunishi Y; Akimori H
    Int J Lepr Other Mycobact Dis; 1981 Dec; 49(4):406-16. PubMed ID: 7042604
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Primary dapsone-resistant leprosy in San Francisco.
    Gelber RH
    Int J Lepr Other Mycobact Dis; 1984 Dec; 52(4):471-4. PubMed ID: 6399067
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Preservation of Mycobacterium leprae in vitro for four years by lyophilization.
    Kohsaka K; Matsuoka M; Hirata T; Nakamura M
    Int J Lepr Other Mycobact Dis; 1993 Sep; 61(3):415-20. PubMed ID: 8228440
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Further study of the effectiveness of single doses of clarithromycin and minocycline against Mycobacterium leprae in mice.
    Xiong JH; Ji B; Perani EG; Pétinon C; Grosset JH
    Int J Lepr Other Mycobact Dis; 1994 Mar; 62(1):37-42. PubMed ID: 8189087
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The mouse foot-pad technique for cultivation of Mycobacterium leprae.
    Levy L; Ji B
    Lepr Rev; 2006 Mar; 77(1):5-24. PubMed ID: 16715686
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Multivariate analysis of the activity of rifamycins against rapidly growing Mycobacteria, to define an in vitro screening model for their activity against mycobacterium leprae.
    Pattyn SR; Hébrant F
    Arzneimittelforschung; 1980; 30(12):2099-103. PubMed ID: 7011330
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.